2026-04-29T06:16:00Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/159222024-09-27T09:32:43Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Gallego-Durán, Rocío author Albillos, Agustín author Ampuero, Javier author Arechederra, María author Bañares, Rafael author Blas-García, Ana author Berná, Genoveva author Caparrós, Esther author Delgado, Teresa C author Falcón-Pérez, Juan Manuel author Francés, Rubén author Fernández-Barrena, Maite G author Graupera, Isabel author Iruzubieta, Paula author Nevzorova, Yulia A author Nogueiras, Rubén author Macías, Rocío I R author Martín, Franz author Sabio, Guadalupe author Soriano, Germán author Vaquero, Javier author Cubero, Francisco Javier author Gracia-Sancho, Jordi author 2022-11 This is a meeting report of the 3rd Translational Hepatology Meeting held in Alicante, Spain, in October 2021. The meeting, which was organized by the Spanish Association for the Study of the Liver (AEEH), provided an update on the recent advances in the field of basic and translational hepatology, with a particular focus on the molecular and cellular mechanisms and therapeutic targets involved in metabolic-associated fatty liver disease (MAFLD), metabolic-associated steatohepatitis (MASH), cirrhosis and end-stage hepatocellular carcinoma (HCC). Gastroenterol Hepatol. 2022 Nov;45(9):724-734. 0210-5705 http://hdl.handle.net/20.500.12105/15922 35248669 10.1016/j.gastrohep.2022.02.005 Gastroenterologia y hepatologia Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH).